Orasure Technologies (OSUR) Shares Outstanding (Diluted Average) (2010 - 2025)
Orasure Technologies' (OSUR) quarterly Shares Outstanding (Diluted Average) came in at $73.0 million in Q3 2025, down 1.78% year-on-year from $74.3 million in Q3 2024, and down 2.27% quarter-over-quarter from $74.7 million in Q2 2025.
Orasure Technologies (OSUR) Shares Outstanding (Diluted Average) (2010 - 2025) Analysis & Trends
Orasure Technologies has disclosed Shares Outstanding (Diluted Average) across 13 years of filings, most recently posting $73.0 million for Q3 2025.
- Shares Outstanding (Diluted Average) for Q3 2025 came in at $73.0 million, down 1.78% year-over-year; the trailing twelve-month figure through Sep 2025 was $73.0 million (down 1.78% YoY), and the FY2024 annual result was $74.4 million, changed 0.06% from the prior year.
- Shares Outstanding (Diluted Average) came in at $73.0 million for Q3 2025 at Orasure Technologies, down from $74.7 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $74.9 million in Q1 2025 to a low of $72.0 million in Q4 2021.
- The 5-year median for Shares Outstanding (Diluted Average) is $74.0 million (2023), against an average of $73.6 million.
- Across the five-year window, Shares Outstanding (Diluted Average) increased 6.63% in 2021 and retreated 1.78% in 2025, its largest moves.
- Orasure Technologies' Shares Outstanding (Diluted Average) stood at $72.0 million in 2021, then advanced by 0.73% to $72.5 million in 2022, then grew by 2.6% to $74.4 million in 2023, then gained by 0.06% to $74.4 million in 2024, then slipped by 1.92% to $73.0 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $73.0 million (Q3 2025), $74.7 million (Q2 2025), and $74.9 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 824.84 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 145.72 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 72.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 175.50 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 195.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 71.61 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Orasure Technologies | 304.09 Mn | 104.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 73.00 Mn |
| Jun 30, 2025 | 74.70 Mn |
| Mar 31, 2025 | 74.87 Mn |
| Dec 31, 2024 | 74.43 Mn |
| Sep 30, 2024 | 74.33 Mn |
| Jun 30, 2024 | 74.13 Mn |
| Mar 31, 2024 | 73.95 Mn |
| Dec 31, 2023 | 74.39 Mn |
| Sep 30, 2023 | 74.20 Mn |
| Jun 30, 2023 | 74.12 Mn |
| Mar 31, 2023 | 73.97 Mn |
| Dec 31, 2022 | 72.51 Mn |
| Sep 30, 2022 | 72.79 Mn |
| Jun 30, 2022 | 72.50 Mn |
| Mar 31, 2022 | 72.19 Mn |
| Dec 31, 2021 | 71.98 Mn |
| Dec 31, 2020 | 67.51 Mn |
| Jun 30, 2020 | 64.75 Mn |
| Mar 31, 2020 | 61.93 Mn |
| Jun 30, 2019 | 62.13 Mn |